BSE · ZENOTECH
Zenotech Laboratories Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#2,277
of 5,004 stocks
▼ 81W
Peak #2,269 · 21 Sep 2026
Operating in Healthcare, Zenotech Laboratories Limited carries a steep earnings multiple that prices in strong future growth, has a subdued return on equity, and remains firmly promoter-controlled, with promoters holding 69%.
Market Cap
255.29 Cr
P/E Ratio
232.39
P/B Ratio
2.68
ROE
-1.13%
ROCE
4.42%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 9.60 Cr | 8.86 Cr | 11.83 Cr | 10.23 Cr |
| Net Profit | -45.55 L | -3.15 Cr | 1.93 Cr | -83.65 L |
| EPS | 0.07 | 0.52 | 0.32 | 0.14 |
| Operating Profit | -60.07 L | -98.96 L | 2.89 Cr | 1.21 Cr |
Shareholding pattern
Promoter
68.84%
Public
31.16%
PUBLIC BREAKDOWN
DII
0.01%
Individuals
23.13%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 01 Jun 2017 | Other | Right Issue of Equity Shares |
| 05 Sep 2002 | Dividend | NIL Dividend - Rs. - 0.0000 |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.